XiaoBing Wang
China Pharmaceutical University
H-index: 36
Asia-China
Top articles of XiaoBing Wang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Discovery of Sibiriline derivatives as novel receptor-interacting protein kinase 1 inhibitors | European Journal of Medicinal Chemistry | Ningjie Cui Shang Li Yonglei Zhang Fucheng Yin Xinye Chen | 2023/3/15 |
Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy | Xinxin Li Cheng Wang Shang Li Fucheng Yin Heng Luo | 2023/12/17 | |
Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer | European Journal of Medicinal Chemistry | Siyuan Wan Xinye Chen Fucheng Yin Shang Li Yonglei Zhang | 2023/12/5 |
Discovery of dual PARP and CDK6 inhibitors for triple-negative breast cancer with wild-type BRCA | Bioorganic Chemistry | Cheng Wang Heng Luo Xinye Chen Yonglei Zhang Dehua Lu | 2023/10/1 |
Design, synthesis and mechanism studies of dual EZH2/BRD4 inhibitors for cancer therapy | Bioorganic & Medicinal Chemistry | Xinye Chen Cheng Wang Dehua Lu Heng Luo Shang Li | 2023/8/15 |
Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease | European Journal of Medicinal Chemistry | Zhongwen Luo Shang Li Yonglei Zhang Fucheng Yin Heng Luo | 2023/8/5 |
Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy | Bioorganic Chemistry | Dehua Lu Lailiang Qu Cheng Wang Heng Luo Shang Li | 2022/3/1 |
Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment | Pharmacology & Therapeutics | Lingyi Kong* Shang Li Lailiang Qu Xiaobing Wang* | 2022/3 |
Histone deacetylase and enhancer of zeste homologue 2 dual inhibitors presenting a synergistic effect for the treatment of hematological malignancies | Journal of Medicinal Chemistry | Dehua Lu Cheng Wang Lailiang Qu Fucheng Yin Shang Li | 2022/9/25 |
Aryl halides as halogenation reagents in the bromination and iodination of arene-tethered diols | Organic Letters | Fucheng Yin Yifan Chen Zhongwen Luo Shang Li Lingyi Kong | 2022/9/2 |
Discovery of precision targeting EZH2 degraders for triple-negative breast cancer | European Journal of Medicinal Chemistry | Cheng Wang Xinye Chen Xingchen Liu Dehua Lu Shang Li | 2022/8/5 |
Rhodium(III)‐catalyzed Cleavage of C−C Bond and C−H Bond Cascaded by Michael Addition for the Conversion of α‐Hydroxy Ketones to Phthalides and … | Asian Journal of Organic Chemistry | Fucheng Yin Wan Peng Cheng Wang Lailiang Qu Xinye Chen | 2022/4 |
Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer | European Journal of Medicinal Chemistry | Lingyi Kong. Huali Yang Xiaobing Wang Cheng Wang Fucheng Yin Lailiang Qu | 2021/1 |
Identification and optimization of Piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2 | European Journal of Medicinal Chemistry | Xiaobing Wang. Limei Ji Lailiang Qu Cheng Wang Wan Peng Shang Li | 2021 |
Parthenolide derivatives as PKM2 activators showing potential in colorectal cancer | Journal of Medicinal Chemistry | Xingchen Liu Cheng Wang Shang Li Lailiang Qu Fucheng Yin | 2021/12/1 |
Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA | Journal of Medicinal Chemistry | and Xiaobing Wang* Cheng Wang Lailiang Qu Shang Li Fucheng Yin Limei Ji | 2021/9 |
Synthesis and Evaluation of Multi-Target-Directed Ligands with BACE-1 Inhibitory and Nrf2 Agonist Activities as Potential Agents against Alzheimer's Disease | European Journal of Medicinal Chemistry | Xiaobing Wang. Lailiang Qu Limei Ji Cheng Wang Heng Luo Shang Li | 2021/7 |
Rhodium(III) catalyzed olefination and deuteration of tetrahydrocarbazole | RSC Advances | Lingyi Kong*， Xiaobing Wang * Wan Peng Qiaohong Liu Fucheng Yin Cunjian Shi Limei Ji | 2021/5 |
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease | RSC Medicinal Chemistry | Ling-Yi Kong Xiao-Bing Wang Fu-Cheng Yin Ming Huang Neng Jiang Jin-Shuai Lan | 2020 |
Development of a tau-targeted drug delivery system using a multifunctional nanoscale metal–organic framework for Alzheimer’s disease therapy | ACS applied materials & interfaces | Jinhua Zhao Fucheng Yin Limei Ji Cheng Wang Cunjian Shi | 2020/9/8 |
